A novel five‐step synthetic route to 1,3,4‐oxadiazole derivatives with potent α‐glucosidase inhibitory potential and their in silico studies
作者:Muhammad Iftikhar、Shahnawaz、Muhammad Saleem、Naheed Riaz、Aziz‐ur‐Rehman、Ishtiaq Ahmed、Jameel Rahman、Muhammad Ashraf、Muhammad S. Sharif、Shafi U. Khan、Thet T. Htar
DOI:10.1002/ardp.201900095
日期:2019.12
ionization mass spectrometry, and high‐resolution electron ionization mass spectrometry analyses. All compounds were evaluated for their α‐glucosidase inhibitory potential. Compounds 6a, 6c–e, 6g, and 6i were found to be promising inhibitors of α‐glucosidase with IC50 values of 81.72 ± 1.18, 52.73 ± 1.16, 62.62 ± 1.15, 56.34 ± 1.17, 86.35 ± 1.17, 52.63 ± 1.16 µM, respectively. Molecular modeling and
通过4-氯苯甲酸的连续转化合成了一系列2-甲基-2-5-(4-氯苯基)-1,3,4-恶二唑-2基硫醇}乙酰胺的新型N-芳基/芳烷基衍生物(a)分别转化为 4-氯苯甲酸乙酯 (1)、4-氯苯甲酰肼 (2) 和 5-(4-氯苯基)-1,3,4-恶二唑-2-硫醇 (3)。通过 1,3,4-恶二唑 (3) 与各种亲电子试剂 (5a-n) 在 DMF(N,N-二甲基甲酰胺)和氢氧化钠的存在下反应获得所需的一系列化合物(6a-n)室内温度。这些化合物的结构测定是通过红外、1H-NMR(核磁共振)、13C-NMR、电子电离质谱和高分辨率电子电离质谱分析完成的。评估了所有化合物的 α-葡萄糖苷酶抑制潜力。化合物 6a, 6c–e, 6g, 和 6i 被发现是有前景的 α-葡萄糖苷酶抑制剂,IC50 值分别为 81.72 ± 1.18、52.73 ± 1.16、62.62 ± 1.15、56.34 ± 1